Head: Dr. Maria Papale, MD


  • Eliuccia Mastropasqua
  • Giorgio Piperno

The Unit has taken part along with “Mario Negri Institute for Pharmacological Research” coordinated by the Italian Association of Hospital Pneumologists (AIPO) in: “Studio multicentrico osservazionale sull’utilizzo della sigaretta elettronica in Italia” and in 2020 has been published in Tumori Journal: “Electronic cigarette use among Italian smokers: patterns, settings, and adverse events”.

The Unit continued to participate in the study BR31 “A phase III prospective double blind placebo controlled randomized study of adjuvant medi4736 in completely resected non-small cell lung cancer”.

The Unit has participated, about the research line 1 “Prevention and early diagnosis of Cancer”, in study “Role of the estradiol axis in the carcinogenesis and prevention of mesothelioma”.

The Unit has taken part in “Registro asma grave- Studio osservazionale e/o retrospettivo non interventistico, multicentrico, nazionale” coordinated by the Italian Association of Hospital Pneumologists (AIPO).

The Unit is taking part in a national, multicentre observational study:

“The impact on the health status and adherence in a real life setting of italian patients with chronic obstructive pulmonary disease in treatment with a fixed triple association pmdi b.i.d.: a 12-month prospective observational study triple therapy in real life: impact on adherence and health status (TRITRIAL)”